Aprea Therapeutics, Inc. (APRE): Capital Expenditures
$15.5K
Year ended 2024-12-31
-12.9%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $15.5K | -83.4% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | $93.1K | n/a | 2025-03-25, From 2023-01-01 |
| No annual figure between 2020-12-31 and 2023-12-31. | |||
| 2020-12-31 | $25.7K | -16.8% | 2023-03-30, From 2020-01-01 |
| 2019-12-31 | $30.9K | +734.7% | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $3.7K | n/a | 2021-03-16, From 2018-01-01 |